Unlocking the Stratum Corneum Barrier to Skin Penetration for the Transdermal Delivery of Cyclovirobuxine D
Pharmaceutics · 16.12.2024 · 16 (12) · 1600
DOI: 10.3390/pharmaceutics16121600 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 16.12.2024. Verfasst von Yun-Hao Ren und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program, National Natural Science Foundation of China, Zhejiang province commonweal projects.
Abstract (Originalsprache)
Background/Objectives: Cyclovirobuxine D, a natural compound derived from the medicinal plant Buxus sinica, demonstrates a diverse array of therapeutic benefits, encompassing anti-arrhythmic properties, blood pressure regulation, neuronal protection, and anti-ischemic activity. However, its limited solubility hinders the bioavailability of current oral and injectable formulations, causing considerable adverse reactions and toxicity.
Methods
In this investigation, we embarked on an unprecedented exploration of the skin penetration potential of cyclovirobuxine D utilizing chemical penetration enhancers and niosomes as innovative strategies to enhance its dermal absorption. These strategies were rigorously tested and optimized.
Results
Among the tested chemical penetration enhancers, azone emerged as the most potent, achieving a 4.55-fold increase in skin penetration compared to the untreated group. Additionally, when encapsulated within niosomes, primarily composed of Span60 and cholesterol, the skin penetration of cyclovirobuxine D was notably enhanced by 1.50-fold. Furthermore, when both cyclovirobuxine D and azone were co-encapsulated within the niosomes, the skin penetration of cyclovirobuxine D was remarkably elevated by 8.10-fold compared to the solvent-dispersed group. This enhancement was corroborated through rigorous in vitro and in vivo experiments. Notably, the combination of other chemical penetration enhancers with niosome encapsulation also exhibited synergistic effects in enhancing the skin penetration of cyclovirobuxine D.
Conclusions
These findings provide a compelling rationale for the administration of cyclovirobuxine D via skin-mediated transdermal delivery, offering superior safety, efficacy, and convenience. The innovative combination of niosomes and chemical penetration enhancers represents a novel system for the transdermal delivery of cyclovirobuxine D, holding immense promise for clinical applications in the treatment of brain, neuronal, and cardiovascular disorders.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
- Jinhua Institute of Zhejiang University, Jinhua 321299, China.
- Hospital of Nanjing Junxie, Nanjing 210002, China.
ORCID-Profile: Li-Hua Peng
Förderung
- National Key Research and Development Program
- National Natural Science Foundation of China
- Zhejiang province commonweal projects
- the Macau Science and Technology Development Fund, Macau Special Administrative Region, China
Zitieren
APA
Ren, Y. H., Song, F. Y., Zhao, J. Y., Liang, B. W., & Peng, L. H. (2024). Unlocking the Stratum Corneum Barrier to Skin Penetration for the Transdermal Delivery of Cyclovirobuxine D. Pharmaceutics, 16(12), 1600. https://doi.org/10.3390/pharmaceutics16121600
Vancouver
Ren YH, Song FY, Zhao JY, Liang BW, Peng LH. Unlocking the Stratum Corneum Barrier to Skin Penetration for the Transdermal Delivery of Cyclovirobuxine D. Pharmaceutics. 2024;16(12):1600. doi:10.3390/pharmaceutics16121600
BibTeX
@article{Ren2024,
author = {Ren, Yun-Hao and Song, Feng-Yuan and Zhao, Jing-Yu and Liang, Bing-Wen and Peng, Li-Hua},
title = {Unlocking the Stratum Corneum Barrier to Skin Penetration for the Transdermal Delivery of Cyclovirobuxine D},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {12},
pages = {1600},
doi = {10.3390/pharmaceutics16121600}
}
EUVIMED